Post Menopausal Osteoporosis – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Post Menopausal Osteoporosis – Drugs In Development, 2024 report and make more profitable business decisions.
Postmenopausal osteoporosis is the most common form of osteoporosis. It affects many women after menopause. Symptoms include back pain, loss of height, or spinal deformities such as stooped posture. Risk factors include age, gender, family history, bone structure, and body weight. Treatment includes hormone replacement therapy (HRT) and vitamin D analogues.
The Post Menopausal Osteoporosis drugs in development market research report provide comprehensive information on the therapeutics under development for Post Menopausal Osteoporosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Post Menopausal Osteoporosis and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Post Menopausal Osteoporosis | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 53 molecules, with 50 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Post Menopausal Osteoporosis therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Post Menopausal Osteoporosis pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Post Menopausal Osteoporosis treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Ablynx NVAddpharma Inc
Airsea (Taizhou) Pharmaceutical Ltd
AlphaMab Co Ltd
Alvotech SA
Amgen Inc
Aryogen Pharmed Co
Aurobindo Pharma Ltd
Beijing Health Guard Biotechnology Inc
Beijing Northland Biotech Co Ltd
Biocon Ltd
Celltrion Inc
Clayton Biotechnologies Inc
Clonz Biotech Pvt Ltd
CSPC Pharmaceutical Group Ltd
Dongkook Pharmaceutical Co Ltd
Eden Biologics Inc
Entera Bio Ltd
Enteris BioPharma Inc
Enzene Biosciences Ltd
Epygen Biotech Pvt Ltd
Fresenius Kabi SwissBioSim GmbH
Gedeon Richter Plc
Genor BioPharma Co Ltd
Hualan Biological Engineering Inc
Ipsen SA
Jiangsu Hansoh Pharmaceutical Group Co Ltd
Jiangsu Hengrui Medicine Co Ltd
Jiangsu T-mab BioPharma Co Ltd
Lupin Ltd
Luye Pharma Group Ltd
Mabxience Holding SL
Monash University
Nano Intelligent Biomedical Engineering Corp
Nanomedic Inc
NeuClone Pty Ltd
Paras Biopharmaceuticals Finland Oy
Radius Health Inc
Reliance Life Sciences Pvt Ltd
Samsung Bioepis Co Ltd
Sandoz Group AG
Shandong New Time Pharmaceutical Co Ltd
Shanghai Braegen Pharmaceutical Co Ltd
Shanghai Henlius Biotech Inc
Shenzhen Salubris Pharmaceuticals Co Ltd
Takeda Pharmaceutical Co Ltd
Teva Pharmaceutical Industries Ltd
Transcenta Holding Ltd
Uni-Bio Science Group Ltd
Univeristy of Zaragoza
University of Montpellier
Wuxi Hebang Biotechnology Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Post Menopausal Osteoporosis reports